Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national
4
×
national blog main
national top stories
new york top stories
novartis
4
×
san francisco top stories
amgen
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
medicare
merck
new york blog main
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
clinical trials
deals
diagnostics
drug prices
What
patients
4
×
bio
drug
roundup
new
therapy
acquisitions
advantages
albert
approved
atrophy
bar
becker
biggest
billions
bourla
brings
ceo
company
crispr
daily
dollars
eaton
evrysdi
expect
fda
friday
future
gamble
gene
green
healthcare
home
impact
imports
intended
life
lights
liquid
maker
Language
unset
unknown
Current search:
novartis
×
patients
×
national
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More